In Brief
The transcriptome of human primordial germ cells from the migrating stage to the gonadal stage reveals that both pluripotency genes and germline-specific genes are simultaneously expressed within the same individual cells. The global erasure of DNA methylation creates a super-hypomethylated germline genome.
INTRODUCTION
From an evolutionary point of view, germ cells are probably one of the most important types of cells in mammalian embryos because they transmit genetic information from one generation to the next and maintain the continuance of the species (Leitch et al., 2013; Saitou and Yamaji, 2012) . The development of mouse primordial germ cells (PGCs) is relatively well understood, including their specification, migration, localization to genital ridges, epigenetic reprogramming, and sex differentiation (Cantone and Fisher, 2013; Lee et al., 2014; Surani et al., 2008) . It has been shown that human gonadal PGCs, in general, express CD117 (also known as KIT) at the cell surface as in mice. However, human PGCs do not express SOX2, in contrast to mouse PGCs (Perrett et al., 2008; Robinson et al., 2001) . Recently, human PGCs in the gonads have been isolated by fluorescenceactivated cell sorting (FACS), and their transcriptome at the 16 week gestation stage has been analyzed (Gkountela et al., 2013) . However, although much progress has been made, the developmental regulation of gene expression in human PGCs is still largely unknown due to the scarcity of materials available for analysis. Here, we analyzed the transcriptomes of 233 individual male and female human PGCs from 15 embryos at between 4 and 19 weeks of gestation, as well as 86 neighboring somatic cells from 13 of these embryos using a single-cell RNA sequencing (RNA-seq) method that we developed. Furthermore, we analyzed the DNA methylomes of both male and female human gonadal PGCs, as well as the neighboring somatic cells of 11 of these embryos at between 7 and 19 weeks of gestation using whole-genome bisulfite sequencing (WGBS). In total, we generated 1.3 billion 100 bp paired-end reads for transcriptome analyses and 4.1 billion 100 bp or 150 bp paired-end reads for DNA methylome analyses.
RESULTS

Transcriptional Profiles of Human PGCs
For human gonadal PGCs between 7 weeks and 19 weeks old, we used a magnetic-activated cell sorting (MACS) or FACS method to enrich KIT (also known as cKIT)-positive PGCs and isolated individual PGCs for single-cell RNA-seq analysis. To address the PGC-niche relationship during this developmental period, we also isolated KIT-negative somatic cells (Figures 1A, S1A, and S1B) . Interestingly, we found that human PGCs were much larger, in general, than the surrounding somatic cells in the gonads. Therefore, we also attempted to isolate the large cells (of comparable size to gonadal PGCs of 7 week embryos) from the aorta-gonad-mesonephros (AGM) region of 4 week embryos. In total, we obtained RNA deep-sequencing data for 233 single PGCs from 15 embryos and 86 neighboring somatic cells from 13 of the embryos. On average, we obtained 4.1 million 100 bp paired-end reads for each individual cell. We detected between 4,111 and 12,149 genes (on average 7,150 genes) expressed (FPKM R 0.1) within each PGC cell and between 1,692 and 8,539 genes (on average 4,526 genes) expressed (FPKM R 0.1) within each gonadal somatic cell (Table  S1 ). Based on the ERCC spike-in, we found that each PGC cell expresses between 94,200 and 279,300 copies of mRNAs, whereas each gonadal somatic cell expresses 50,900 and 147,000 copies of mRNAs ( Figure S1C ). First, we performed unsupervised hierarchical clustering analysis of the single PGCs and their neighboring somatic cells. As a control, we also included 11 individual cells from the inner cell mass (ICM) of the blastocysts, as previously described (Yan et al., 2013) . We found that the 233 PGCs clustered together with pluripotent ICM but were clearly separated from the 80 gonadal somatic cells, as expected ( Figure 1B) . Interestingly, the six somatic cells at the AGM region of 4 week embryos clustered together with PGCs ( Figure 1B ). We analyzed these six cells and found that they expressed hematopoietic marker genes, such as MEIS1 and PBX1, and were probably hematopoietic precursor cells ( Figure S1D ). Within the PGC cluster, a majority of the 17 week female PGCs and some of the 19 week male PGCs were separated from earlier stage PGCs, indicating that the PGCs entering meiosis were significantly different from those in mitotic stages ( Figure 1B) . Interestingly, the PGCs at different time points before 11 weeks were intermingled, indicating that, although there were some developmental-stagespecific changes in gene expression, the transcriptomes of PGCs between 4 week and 11 week embryos are, in general, stable and similar to each other.
Next, we performed principal component analysis (PCA) to compare the transcriptomes of PGCs with those of human preimplantation embryos ( Figure 1C ). The PC2 axis was dominated by the differences among preimplantation embryos. On this axis, the embryos showed clear step-wise transcriptome changes from oocytes to blastocysts. The PC1 axis showed the differences between mitotic and meiotic PGCs. PGCs in mitosis before 11 weeks were tightly clustered together and were, in general, similar to pluripotent ICM cells but were distinct from the 19 week male PGCs and 17 week female PGCs in meiosis ( Figure 1C) . Moreover, the 17 week female PGCs scattered far from each other, indicating that there was strong heterogeneity among these PGCs in meiosis. The heterogeneity of 19 week male PGCs was less striking than that of 17 week female PGCs. This finding implied that the migrating and gonadal PGCs in mitosis are relatively homogeneous and similar to each other during the 4 to 11 week development period, whereas the gonadal PGCs in meiosis are very different from those in mitosis and are highly heterogeneous. To exclude the possibility that the mitotic PGCs were intermingled with each other due to cell-cycle-related heterogeneity, we analyzed them with a single-cell latent variable model (scLVM) method to remove the cell-cycle-related variations (Buettner et al., 2015) . We found that, before 11 weeks, the PGCs were still clustered together, whereas 17 week female PGCs and some 19 week male PGCs separated from the clusters and dispersed from each other ( Figure S1E ). This finding verified that mitotic PGCs are relatively homogeneous and exhibit only minor developmental stage-specific changes in their transcriptomes.
We also compared PGCs with other relevant types of cells in both humans and mice by PCA analysis using one-to-one homolog genes shared by humans and mice ( Figure S1F ). We found that mouse PGCs are, in general, similar to human PGCs, as expected. Moreover, human PGCLCs in vitro were similar to human mitotic PGCs in vivo, indicating that they are a good model system for early human PGC development. Both naive and primed human embryonic stem cells (hESCs) are similar to human ICM, with naive hESCs exhibiting the greater similarity.
Human mitotic PGCs clearly express pluripotency marker genes such as POU5F1 (also known as OCT4), NANOG, ZFP42 (also known as REX1), DPPA3 (also known as STELLA), SALL4, and LIN28A, but not SOX2, as previously reported (Hayashi et al., 2011; Magnú sdó ttir et al., 2013; Ohinata et al., 2009) (Figures 1D, 2 , and S2). These PGCs also express germline specific marker genes, such as KIT, ALPL (also known as TNAP), TFAP2C (also known as AP2g), DND1, NANOS3, and TCL1A (Figures 2 and S2) . Recently, it has been shown that SOX17 is a master regulator for human PGC specification in vitro (Irie et al., 2015) . We found that SOX17 was clearly expressed in migrating and gonadal PGCs, especially in male PGCs. More interestingly, SOX15 was expressed more homogenously and at a much higher level specifically in PGCs, especially at early stages before 10 weeks (Figure 2 ). This pattern indicates that, for migrating and early gonadal PGCs, SOX15 is probably functionally more pivotal for PGC development in vivo.
Some of the germ cell marker genes also showed developmental-stage-specific expression patterns. For example, T and CD38 were expressed in the early PGCs at between 4 weeks and 7 weeks, whereas DDX4 (also known as VASA), DAZL, TDRD9, and SYCP3 were expressed mainly after 7 weeks (Figure 2 and Figure S2 ). SYCP1 and SYCE3 were specifically expressed in meiotic PGCs. The piRNA-binding protein Miwi has been found to play an important role during mouse germ cell development (Chuma and Nakano, 2013; Juliano et al., 2011) . Interestingly, PIWIL1 (also known as MIWI) was expressed in human PGCs throughout the period that we analyzed (Figure 2 ), indicating that piRNAs are probably intensely involved in the development of the migrating and gonadal stage PGCs. The DNA dioxygenase TET1 is also highly expressed in PGCs from 4 weeks to 11 weeks, with TET2 and TET3 only mildly expressed ( Figure S2 ), indicating that active demethylation probably occurs in human PGCs during this developmental period, similar to its occurrence in mouse PGCs at comparable developmental stages (Hackett et al., 2013; Vincent et al., 2013; Yamaguchi et al., 2012 Yamaguchi et al., , 2013 .
However, in our study, the gonadal somatic cells expressed WT1, a specific marker gene for Sertoli cells in males and cumulus cells in females (Wilhelm et al., 2007) , indicating that at least some of these somatic cells are Sertoli cells or cumulus cells. In addition, some of these cells expressed GATA6 and KITLG (also known as SCF), indicating that the gonadal somatic cells probably contained distinct sub-populations (Figures 2 and S2 ).
Dynamic Gene Expression Patterns in Human Primordial Germ Cells
We next analyzed the major differences among ICM, PGCs, and the surrounding somatic cells. We found 988 mitotic PGC-specific genes and 1,325 gonadal somatic cell-specific genes ( Figure 3A and Table S2 ). The pathway analysis showed that PGCs were strongly enriched with genes involved in the base excision repair (BER) pathway ( Figure S3A ), similar to those in mouse PGCs at comparable developmental stages (Hajkova et al., 2010; Kagiwada et al., 2013; Wossidlo et al., 2010) . This finding indicates that migrating and gonadal PGCs probably have a strong requirement for BER-related mechanisms, probably due to global DNA demethylation and other epigenetic reprogramming processes.
Moreover, in male PGCs, we found 814, 98, 852, 352, and 1,829 genes that were specifically expressed at 4 weeks (such as T, PROM1, and OGT), 7 weeks (such as ECD, FDPS, and NSDHL), 10 weeks (such as SMUG1, PRMT6, and SIRT1), 11 weeks (such as CPEB1, KLF5, and TFCP2L1), and 19 weeks (such as TEX14, TEX15, and TDRD6), respectively ( Figure 3B and Table S3 ). This indicates the considerable number of genes with developmental stage-specific expression patterns during male PGC development, especially for the mitotic arrest PGCs at 19 weeks. We did gene ontology (GO) analysis and found that 19 week male PGCs showed specific enrichment for terms such as spermatogenesis and sexual reproduction ( Figure 3B and Table S3 ). This is compatible with the notion that, although 19 week male PGCs are in mitotic arrest, they already express at RNA level a significant number of spermatogenesis genes. Recently, it has been unexpectedly shown that T, a mesoderm master gene, is specifically expressed in mouse early PGCs during specification (Aramaki et al., 2013) . We found that, in fact, T is specifically expressed in early PGCs in human embryos at between 4 weeks and 7 weeks ( Figure 2 and Table S3 ).
Comparably, for female PGCs, we found 254, 497, 251, and 34 genes that were specifically expressed in PGCs at 4 weeks (such as T, ACTC1, and IFITM3), 8 weeks (such as UNG, LMO4, and PLK1), 10 weeks (such as SUMG1, DMRT1, and NDUFA3), and 11 weeks (such as FES), respectively ( Figure 3B and Table  S3 ). This result indicates that there is a small but consistent number of genes showing developmental-stage-specific expression patterns during female PGC development at mitotic stages. However, 17 week female PGCs showed 5,748 specifically expressed genes (such as SYCP1, SYCE3, and IL13RA2), indicating that meiotic female PGCs at 17 weeks are sharply different from earlier mitotic PGCs ( Figure 3B and Table S3 ). We did GO analysis, and these 17 week specific genes clearly enriched for terms such as meiotic cell cycle and chromosome organization involved in meiosis. This suggests that 17 week female PGCs entered meiosis arrest and showed striking meiosis-related features.
Next, we analyzed the general expression pattern of pluripotency-related genes during PGC development. We found that the total expression levels of pluripotency genes in each PGC clearly decreased from 4 weeks to 19 weeks in both male and female embryos ( Figure 3C and Table S6 ). On the contrary, the total expression levels of meiosis-related genes in each female PGC increased strikingly from 11 weeks to 17 weeks, indicating that 17 week female PGCs entered meiosis already ( Figure 3C and Table S6 ).
Furthermore, we analyzed the sex-specific genes ( Figure S3B and Table S4 ). For the PGCs, 443 genes showed higher expression in mitotic male PGCs than in their female counterparts. By contrast, only 50 genes showed higher expression in mitotic female PGCs than in their male counterparts. For the gonadal somatic cells, 934 genes were expressed at higher levels in male somatic cells than in their female counterparts, whereas only 223 genes were expressed at higher levels in female somatic cells. This indicates that male gonads have more uniquely expressed genes than female gonads at between 4 weeks and 11 weeks.
Heterogeneity of Gene Expression in Human PGCs within an Embryo
To analyze the heterogeneity of gene expression of individual PGCs within the same embryo, we performed ''pool-and-split'' cell RNA-seq experiments (Marinov et al., 2014) (Figures S3C  and S3D and Table S5 ). In this way, we obtained the transcriptome of ''average'' single PGCs. By comparing the transcriptomes of real individual PGCs to those of ''average'' single PGCs, we could clearly identify the genes that showed heterogeneous expression among the PGCs within the same embryo. We found 96, 197, 1,792, and 519 genes showing clear heterogeneous expression patterns in 7 week, 8 week, 17 week, and 19 week PGCs, respectively ( Figures S3C and S3D ). For example, SYCP1 was heterogeneously expressed in 17 week female PGCs. This finding indicates that 17 week female PGCs in meiosis exhibit a strong heterogeneity of gene expression among individual cells.
Reactivation of X Chromosomes in Human Female PGCs
During mouse female PGC development, the inactivated X chromosome is reactivated between E8.5 and E12.5 (Chuva de Sousa Lopes et al., 2008) . We analyzed this behavior in human PGCs by analyzing the expression of genes on the X chromosome ( Figure 4A ). Compared with male PGCs at between 4 weeks and 11 weeks, the total expression level of the genes on the X chromosome increased 1.6-fold in female counterparts ( Figure 4B and Table S6 ). This indicates that the inactivated X chromosome is already reactivated in female PGCs from 4 weeks onward. Moreover, we analyzed the allelic-specific expression of the genes on the X chromosome. In a 4-week embryo, the female PGCs showed bi-allelic expression of the gene HDHD1 (showing heterozygous SNP C/A), whereas the gonadal somatic cells in the same embryo showed monoallelic expression (showing either SNP C or A due to X chromosome random inactivation) ( Figure 4C and Table S6 ). This was also the case for later-stage female PGCs. This demonstrates that, at 4 weeks after gestation, the inactivated X chromosomes in PGCs are already reactivated and show biallelic expression. Figure S1A ). Then, we used a post-bisulfite adaptor tagging (PBAT) technique to perform WGBS (Miura et al., 2012; Smallwood et al., 2014) . As a control, we also performed WGBS on brain and heart tissues of a 5 week post-implantation embryo. We found that, in the 5 week embryo, the global DNA methylation level was more than 80%, as expected ( Figure 5A ). However, in the male PGCs of 7 week embryos, the methylation level had already decreased to 19.4%, indicating that the major wave of global DNA demethylation occurred in the PGCs before 7 weeks of development ( Figure 5A ). The biological variation of DNA methylation between the two male 7 week embryos was minimal, with less than a 1.3% difference between the two embryos. Three weeks later, the DNA methylation further dropped to 11.7% in the male PGCs of 10 week embryos, and the lowest level of DNA methylation was achieved in the male PGCs of 11 week embryos, with only 7.8% methylation remaining in the whole genome ( Figure 5A ). The technical variation was also minimal, with less than a 0.2% difference between the two technical replicates. Later, the low methylation levels in the male PGCs of 13 and 19 week embryos were maintained, implying that global re-methylation in male PGCs should occur after 19 weeks. During the global demethylation process in the PGCs, the gonadal somatic cells maintained a high level of DNA methylation, as expected. In parallel, we also analyzed the DNA methylome dynamics in female PGCs. The lowest level of DNA methylation was achieved in the female PGCs of 10 week embryos, with only 5.8% and 6.1% methylation remaining in the entire genome in the two biological replicates, which was achieved 1 week earlier than that in male PGCs. As far as we know, this is the lowest DNA methylation level in the human genome for any type of cell analyzed, and it indicates that the PGCs in 10 week female embryos, as well as in 11 week male embryos, have a very hypomethylated genome ( Figure 5A ). One week later, the DNA methylation was already increased to 9.0% in 11 week female PGCs. This level was maintained in the 17 week female PGCs. This indicates that global remethylation in female PGCs starts at 11 weeks of gestation, which is much earlier than in male PGCs.
Next, we analyzed the DNA methylation on and around the gene body region. We found that, during global demethylation, both the gene body region and the surrounding intergenic region were heavily demethylated, whereas the gene bodies still had slightly higher levels of methylation than the neighboring intergenic regions ( Figure 5B ). When the lowest methylation level was achieved in the male PGCs of 11 week embryos and the female PGCs of 10 week embryos, on average, only 5.5% and 4.5%, respectively, of methylation remained in the gene bodies ( Figure 5B) .
Next, we compared our DNA methylome data for human PGCs with those of other relevant cell types in both humans and mice by PCA analysis. We aligned the homologous regions between the human and mouse genomes and compared the methylation levels within each 1 kb window for all the samples (see the Experimental Procedures for the details) ( Figure 5C ). The PC2 axis had the most differences between the two species. All the mouse samples were on the upper axis, whereas all the human samples were on the lower axis. The PC1 axis was dominated by differences in the DNA methylation levels within each species. For the human samples, the highly methylated post-implantation tissues such as brain, heart, and liver, as well as sperm and primed hESCs, were located on the right side. The median-level methylated reset/naive hESCs and ICM were in the middle. The low-level methylated PGCs were located on the left side. Comparably, for the mouse samples, the hypermethylated E6.5 post-implantation epiblasts were on the right side. The hypomethylated gonadal PGCs from E9.5 to E13.5 moved from middle to left when the DNA methylation was globally decreased. The male PGCs at E16.5 moved backward to the middle section because their genome was already globally remethylated. This pattern indicates that the DNA methylomes of human PGCs between 7 weeks and 19 weeks are roughly comparable to those of mice between E10.5 and E13.5.
Next, we analyzed the non-CpG methylation in human PGCs. We found that human PGCs between 7 and 19 weeks have 1% non-CpG methylation, whereas the gonadal somatic cells during this period have 2% to 6% non-CpG methylation. This suggests that human gonadal PGCs only have marginal level of DNA methylation on non-CpG sites ( Figure 5D ).
Recently, it has been shown that DNA methylation (5mC) can be demethylated through oxidation into hydroxymethylation (5hmC) by TET family proteins (Kohli and Zhang, 2013) . First, we analyzed the 5hmC distribution by immunostaining (Figure 5E ). We found that 5hmC was mainly enriched in the somatic cells in the 7 to 11 week gonads. The level of 5hmC in the PGCs during this period was very low. Next, we analyzed the hydroxymethylation patterns at a single-base resolution in male PGCs of a 10 week embryo with the Tet-assisted bisulfite sequencing (TAB-seq) technique (Yu et al., 2012) . We found that, on average, there was 1.9% of 5hmC in their genome. This finding indicates that there is a low but significant level of 5hmC in the mitotic PGCs in the gonads. Then, we analyzed the distribution of 5hmCs in the PGC genome. Similarly to 5mC, the 5hmC also enriched on the gene body but to a milder extent ( Figure 5F ). Table S6 for the details. We found that the genic regions showed the higher levels of 5hmC, whereas most of the repetitive elements showed much lower levels of 5hmC ( Figure 5G ).
The Methylation Dynamics of Imprinting Genes and Germline-Specific Genes in Human PGCs
During mouse PGC development in the gonads, the differentially methylated regions (DMRs) of imprinting genes must be thoroughly demethylated. Similarly, we found that, in the 7 week PGCs, the DMRs were strongly demethylated, and from 10 weeks onward, the DMRs were essentially free of any methylation ( Figures 6A and S4 ). By contrast, the methylation of DMRs was faithfully maintained in the neighboring somatic cells in the gonads. This hypomethylated status of the DMRs was maintained in PGCs until 19 weeks, indicating that the remethylation and re-establishment of imprinting occurred after that, probably in a time course similar to that in mice. Comparably, the promoter regions of germline-specific genes were strikingly demethylated in the 7 week PGCs, and from 10 weeks onward, these promoters were essentially free of any methylation ( Figures 6A and S4 ).
The Methylome Dynamics of Functional Genomic Elements in Human PGCs
In general, the DNA demethylation on different functional genomic elements mirrors that of the global pattern but with the extent varied. The median DNA methylation level of the promoter regions in 5 week embryos was 27.0%, and it gradually decreased to 2.0% and 1.0%, respectively, in the 11 week male PGCs and the 10 week female PGCs ( Figures  6B and S5 ). More dramatically, the median global methylation level of all the 287,744 known enhancers was 86.8% in the 5 week embryos. However, it decreased to as low as 4.3% and 2.8%, respectively, in the 11 week male PGCs and the 10 week female PGCs ( Figures 6B and S5B ), potentially avoiding transmission of these epigenetic memories to the later germ cells, as well as the next-generation individuals. For the three major types of transposable elements (TEs)-long interspersed nuclear elements (LINEs), short interspersed nuclear elements (SINEs), and long terminal repeats (LTRs)-the median DNA methylation levels were 91.7%, 95.6%, and 92.6% in the 5 week embryos and decreased to 8.7%, 8.2%, and 7.7% in the 11 week male PGCs and 8.8%, 5.9%, and 7.7% in the 10 week female PGCs, respectively ( Figure 7E ). When we analyzed the subfamilies of LINEs, we found that the evolutionarily younger L1 has higher levels of residual methylation than the evolutionarily older L2, with L1 still exhibiting 22.2% and 24.0% methylation in the 11 week male PGCs and 10 week female PGCs, respectively ( Figure 7A) . Similarly, the evolutionarily younger Alu subfamily of SINEs has higher levels of residual methylation than the evolutionarily older MIR subfamily, with Alu still exhibiting 12.5% and 12.3% methylation in the 11 week male PGCs and 10 week female PGCs, respectively ( Figure 7B ). This indicates that, during the global DNA demethylation process in the PGCs, the evolutionarily younger and more active transposable elements maintain higher levels of residual methylation than the older and less active ones. Correspondingly, the level of RNA transcripts of the L1 subfamily was consistently higher than that of L2 ( Figure 7C ). In addition, the level of RNA transcripts of the Alu subfamily was consistently higher than that of MIR ( Figure 7D ). This pattern indicates that the evolutionarily younger transposable elements are transcribed more actively than the evolutionarily older ones. In addition, the evolutionarily younger and more active repeat elements, such as L1, Alu, and ERVK (Figures 7 and S5B) , had relatively high levels of residual DNA methylation, even when the whole genome of the male PGCs in the 11 week embryos and the female PGCs in the 10 week embryos were nearly devoid of any methylation. Similarly, the alpha satellites (ALRs), which concentrate in centromeric and peri-centromeric regions (Schueler and Sullivan, 2006) , still maintained 36.5% DNA methylation in both the 11 week male PGCs and 10 week female PGCs ( Figure 7E ). This indicates that these repetitive elements still highly methylated when the global DNA methylation is minimal in PGCs, which has also been observed in the mouse germline (Kobayashi et al., 2013; Seisenberger et al., 2012) and suggests a basis for potential trans-generation inheritance of epigenetic memory.
The Dynamics of Histone Modifications in Human PGCs
We analyzed the histone modifications in human PGCs by immunostaining. We found that, for the H3K9me3, mitotic PGCs between 7 weeks and 11 weeks showed clear signals with striking punctuated dots, which were probably constitutive heterochromatins ( Figure S6 ). The finding that the residual DNA methylation was already minimal in the 10 week female PGCs and 11 week male PGCs implies that the H3K9me3 is probably the main factor marking and repressing the constitutive heterochromatin in PGCs during this period.
We also analyzed H3K27me3 and found that mitotic PGCs in both female and male gonads showed very low signals (Figure S6) . Interestingly, in the 7 and 10 week female gonads, there was a clear H3K27me3 dot in each somatic cell, marking the inactivated X chromosomes in these cells. However, in the PGCs of these gonads, such foci disappeared, indicating that the inactivated X chromosome is already reactivated in these female PGCs.
Relationship between DNA Methylation and Gene Expression DNA methylation at the gene promoter region usually represses the expression of the corresponding gene (Jones, 2012; Xie et al., 2013) . We analyzed the relationship between RNA expression and DNA methylation at the promoter regions of the corresponding genes. We found that the negative correlation between these regions was still present in the PGCs even after global demethylation, as in the somatic cells ( Figure S7A ). However, the extent of the negative correlation was weaker in the PGCs than in the neighboring gonadal somatic cells, especially in the female PGCs of 10 week embryos ( Figure S7A ). This indicates that, although promoter DNA methylation still represses gene expression in the PGCs, the regulation extent is clearly milder than in the somatic cells. However, it has been shown that DNA methylation in gene bodies is usually positively correlated with gene expression (Bird, 2002; Jones, 2012; Xie et al., 2013) . We analyzed this discrepancy and found that the DNA methylation levels in the gene bodies of genes that were not expressed were still lower than those of expressed genes, indicating that DNA methylation in the gene bodies is still potentially involved in promoting gene expression in PGCs, although to a much lesser extent ( Figure S7B ).
DISCUSSION
To our knowledge, for the first time, the transcriptome of human PGCs of migrating and gonadal stages was analyzed at single-cell and single-base resolutions. We found that, during the 7 weeks of development in the 4 week to 11 week embryos, the transcriptomes of the PGCs were stable in general ( Figures  1B and 1C) , with only several hundreds of genes changing their expression significantly ( Figure 3B ). By contrast, the global DNA methylation was drastically decreased to 7.8% in the 11 week male PGCs and 6.0% in the 10 week female PGCs during this developmental period ( Figure 5A ). This is very similar to the patterns in mice. How the PGCs maintain relatively stable RNA expression pattern when the DNA methylation is globally removed warrants further analysis.
Another interesting finding is that the gonadal somatic cells showed strong heterogeneous gene expression patterns (Figure 1B) . This finding is compatible with the notion that, at these developmental stages, the somatic cells in the gonad have probably already differentiated into different types of cells, such as Sertoli cells and Leydig cells in male embryos (Wilhelm et al., 2007) .
A third interesting finding is the strong gene expression heterogeneity of 17 week meiotic female PGCs ( Figures 1C  and S1E ). This indicates that, after entering meiosis, the transcriptomes of individual female PGCs not only change strikingly compared with their mitotic precursors but also differ dramatically from each other.
A fourth interesting point is that the inactivated X chromosome was already reactivated in the 4 week female PGCs (Figure 4) . More intriguingly, compared with the male PGCs at a similar stage, the total expression level of the genes on the X chromosome in female PGCs was 1.6-fold, but not 2-fold, higher. This indicates that either the expression of the genes on the single-copy X chromosome in an individual male PGC is globally enhanced or that gene expression on the double copies of X chromosomes in a female PGC is globally suppressed or that a combination of these responses occurred, which warrants further investigation.
A fifth interesting point is that human PGCs showed strong enrichment of the BER pathway ( Figure S3A ). This finding is compatible with the possibility that the BER pathway is heavily involved in the global DNA demethylation process in PGCs, especially active demethylation (Ooi and Bestor, 2008) .
A sixth finding of interest is that global DNA demethylation in the PGCs was much more thorough than the first wave in preimplantation embryos. The DNA methylation level was decreased from over 80% in the early post-implantation embryos to less than 8% in the 11 week male PGCs and 10 week female PGCs. However, for the first wave of global demethylation before implantation, the DNA methylation level was decreased from 86% in the sperm to just 43% in the ICM of blastocyst-stage embryos . In this second wave of global demethylation, the enhancers were exceptional. The median global methylation level of all the over 0.28 million known enhancers was decreased from 86.8% in the 5 week embryos to as low as 4.3% in the 11 week male PGCs and 2.8% in the 10 week female PGCs (Figures 6B and S5B ). Such low levels will potentially prevent the transmission of these epigenetic memories on the functionally important enhancers to the later germ cells, as well as the next-generation individuals.
A seventh point is that, during this second wave of global demethylation, the evolutionarily younger and more active (Seisenberger et al., 2012) , primed and reset hESCs (Takashima et al., 2014) , and human ICM cells Placental Imprinting DMRs (n=15) transposable elements have higher levels of residual methylation than the evolutionarily older elements ( Figures 7A-7D ), as occurred during the first wave of global demethylation in preimplantation embryos, as we and others have reported Smith et al., 2014) . In summary, the transcriptome and DNA methylome landscapes of human migrating and gonadal PGCs are in general similar to those of mouse PGCs at comparable stages. At the same time, human PGCs also show unique features different from mouse PGCs. Our work paves the way to elucidating the complex relationship of DNA methylation and the gene expression network during the global epigenetic reprogramming process of human PGCs.
EXPERIMENTAL PROCEDURES Informed Consent and Sample Collection
This study was approved by the Reproductive Study Ethics Committee of Peking University Third Hospital (2012SZ013). All of the patients signed informed consents and voluntarily donated the samples for our study. The samples were from aborted fetuses at 4 to 19 weeks of gestation. Fetal gonads were identified and dissected under microscopes.
Preparation of Single-Cell cDNAs from Human PGCs or Gonadal Somatic Cells
The protocol for single-cell RNA-seq has been published previously (Tang et al., 2009 (Tang et al., , 2010 . Briefly, after a MACS or FACS procedure, a single PGC or somatic cell was randomly picked by using a mouth pipette and transferred into lysate buffer. Additionally, diluted ERCC mix (Life Technology 4456740) (Table S1 ) was added as spike-in for a single cell. Then, the reverse transcription reaction was performed, and terminal deoxynucleotidyl transferase was used to add a poly(A) tail to the 3 0 end of the first-strand cDNA. After the second-strand cDNA synthesis, 23 cycles of PCR were performed to amplify the single-cell cDNA. qPCR analysis was performed using a set of housekeeping genes (GAPDH or RPS24) combined with OCT4 or VASA to check the quality of the amplified single-cell cDNAs and cell type. Notably, the ''pool-and-split'' RNA-seq experiments were performed as control to analyze the biological heterogeneity of gene expression in the PGCs within each individual embryo. Briefly, nine single PGCs were pooled and lysed together and then split equally into nine reaction tubes with each one as an ''averaged'' single cell. Each ''averaged'' single cell sample was processed by the single-cell RNA-seq protocol and was sequenced with similar depths. Using these ''averaged'' cell samples as control, the biological variations of gene expression for the PGCs within each individual embryo were calculated (Marinov et al., 2014; Streets et al., 2014) .
DNA Extraction and PBAT Library Construction
The KIT-positive PGCs that were obtained by FACS were further washed with DPBS, and then DNA was isolated from the cell pellets using DNeasy Blood & Tissue Kits (QIAGEN). Samples of 5-100 ng of genomic DNA were used to construct the PBAT library, as previously described with minor modifications (Miura et al., 2012; Smallwood et al., 2014) . Briefly, the isolated genomic DNAs, together with 1% unmethylated lambda DNA (Thermo Scientific), were subjected to bisulfite conversion using a MethylCode Bisulfite Conversion Kit (Invitrogen) according to the manufacturer's instructions. The bisulfiteconverted templates were then annealed using random nonamer primers with a 5 0 biotin tag and a truncated Illumina P5 adaptor (5 0 -biotin-CTACACG ACGCTCTTCCGATCTNNNNNNNNN-3 0 ) supplemented with 50 units of klenow polymerase (3 0 to 5 0 exo-, New England Biolabs). The excess primers were removed using 40 U exonuclease I (NEB) before DNA was purified using 0.8 3 Agencourt Ampure XP beads (Beckman Coulter). Then, the newly synthesized DNA strands were immobilized using the Dynabeads M280 Streptavidin (Invitrogen), and the original bisulfite-treated DNA templates were removed via two rounds of 0.1 N NaOH washes. The second strands were synthesized using 50 units klenow polymerase (3 0 to 5 0 exo-, NEB)
with random nonamer primers containing a truncated P7 Illumina adaptor (5 0 -AGACGTGTGCTCTTCCGATCTNNNNNNNNN-3 0 ). The beads were further collected and washed several times, and the library was generated with 4-6 cycles of PCR amplifications using 1 U Kapa HiFi HS DNA Polymerase Amplified libraries were purified with 0.8 3 Agencourt Ampure XP beads twice and were assessed on the Agilent Bioanalyzer 2100 platform and quantified with a standard curve-based qPCR assay (Kapa Biosystems). The final quality-ensured libraries were pooled and sequenced on the Illumina HiSeq2000/ 2500 sequencer for 100 bp or 150 bp paired-end sequencing.
ACCESSION NUMBERS
1.36 Tb sequencing data were generated for this work. All of these RNA-seq, PBAT, and TAB-seq sequencing data were deposited in the NCBI Gene Expression Omnibus (GEO) under accession number GEO: GSE63818. (A) Heatmap of DNA methylation levels (CpG sites) of known human imprinting DMRs and representative germline-specific genes. The imprinted DMR coordinates were taken from Court et al. (2014) and then classified into four categories, including maternal imprinting DMRs, paternal imprinting DMRs, somatic DMRs, and placental-specific DMRs according to the previous publication (Okae et al., 2014) . 
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